Clinical Efficacy of Retroauricular Injection of Methylprednisolone Sodium Succinate in the Treatment of Sudden Deafness with Type 2 Diabetes
CONCLUSION: Treatment with postauricular injection of methylprednisolone sodium succinate has shown better therapeutic recovery in patients with sudden deafness, improved pure-tone hearing threshold, reduced risk of blood glucose elevation, and improved clinical outcomes for patients with sudden deafness, providing some reference for the treatment of patients with sudden deafness.PMID:35912152 | PMC:PMC9337928 | DOI:10.1155/2022/3097436 (Source: Computational and Mathematical Methods in Medicine)
Source: Computational and Mathematical Methods in Medicine - August 1, 2022 Category: Statistics Authors: Zhenbo Zhong Xiaofei Wang Kairui Xu Jing Tao Source Type: research

Compatibility and stability of methylprednisolone sodium succinate and granisetron hydrochloride in 0.9% sodium chloride solution
A combination of methylprednisolone sodium succinate (MSS) and granisetron hydrochloride (GH) is generally devoted to treating the chemotherapy-induced nausea and vomiting. To date, none of these novel mixtures have been commercially available. The present study was aimed at investigating physical and chemical compatibility and stability of a combination of MSS with GH in 0.9% sodium chloride injection for 72 hours at 4°C and 25°C. (Source: Medicine)
Source: Medicine - July 15, 2022 Category: Internal Medicine Tags: Research Article: Observational Study Source Type: research

A Case Report of MPO-ANCA-Associated Vasculitis Following Heterologous mRNA1273 COVID-19 Booster Vaccination
J Korean Med Sci. 2022 Jul 4;37(26):e204. doi: 10.3346/jkms.2022.37.e204.ABSTRACTDespite that clinical trials have been examining the safety profile of coronavirus disease 2019 (COVID-19) vaccines, there are concerns about long-term side effects as the number of vaccinations increases. Herein, we report a case of new-onset renal-limited anti-myeloperoxidase (MPO) antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis after booster vaccination with the mRNA 1273 (Moderna) vaccine. A 72-year-old woman with no specific past history, and who had a normal renal function, developed ANCA-associated vasculitis following ...
Source: Journal of Korean Medical Science - July 5, 2022 Category: Biomedical Science Authors: Beop Chang Kim Han Seong Kim Kum Hyun Han Sang Youb Han Hyung Ah Jo Source Type: research

A Case Report of MPO-ANCA-Associated Vasculitis Following Heterologous mRNA1273 COVID-19 Booster Vaccination
J Korean Med Sci. 2022 Jul 4;37(26):e204. doi: 10.3346/jkms.2022.37.e204.ABSTRACTDespite that clinical trials have been examining the safety profile of coronavirus disease 2019 (COVID-19) vaccines, there are concerns about long-term side effects as the number of vaccinations increases. Herein, we report a case of new-onset renal-limited anti-myeloperoxidase (MPO) antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis after booster vaccination with the mRNA 1273 (Moderna) vaccine. A 72-year-old woman with no specific past history, and who had a normal renal function, developed ANCA-associated vasculitis following ...
Source: J Korean Med Sci - July 5, 2022 Category: General Medicine Authors: Beop Chang Kim Han Seong Kim Kum Hyun Han Sang Youb Han Hyung Ah Jo Source Type: research

A Case Report of MPO-ANCA-Associated Vasculitis Following Heterologous mRNA1273 COVID-19 Booster Vaccination
J Korean Med Sci. 2022 Jul 4;37(26):e204. doi: 10.3346/jkms.2022.37.e204.ABSTRACTDespite that clinical trials have been examining the safety profile of coronavirus disease 2019 (COVID-19) vaccines, there are concerns about long-term side effects as the number of vaccinations increases. Herein, we report a case of new-onset renal-limited anti-myeloperoxidase (MPO) antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis after booster vaccination with the mRNA 1273 (Moderna) vaccine. A 72-year-old woman with no specific past history, and who had a normal renal function, developed ANCA-associated vasculitis following ...
Source: Journal of Korean Medical Science - July 5, 2022 Category: Biomedical Science Authors: Beop Chang Kim Han Seong Kim Kum Hyun Han Sang Youb Han Hyung Ah Jo Source Type: research

A Case Report of MPO-ANCA-Associated Vasculitis Following Heterologous mRNA1273 COVID-19 Booster Vaccination
J Korean Med Sci. 2022 Jul 4;37(26):e204. doi: 10.3346/jkms.2022.37.e204.ABSTRACTDespite that clinical trials have been examining the safety profile of coronavirus disease 2019 (COVID-19) vaccines, there are concerns about long-term side effects as the number of vaccinations increases. Herein, we report a case of new-onset renal-limited anti-myeloperoxidase (MPO) antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis after booster vaccination with the mRNA 1273 (Moderna) vaccine. A 72-year-old woman with no specific past history, and who had a normal renal function, developed ANCA-associated vasculitis following ...
Source: J Korean Med Sci - July 5, 2022 Category: General Medicine Authors: Beop Chang Kim Han Seong Kim Kum Hyun Han Sang Youb Han Hyung Ah Jo Source Type: research

A Case Report of MPO-ANCA-Associated Vasculitis Following Heterologous mRNA1273 COVID-19 Booster Vaccination
J Korean Med Sci. 2022 Jul 4;37(26):e204. doi: 10.3346/jkms.2022.37.e204.ABSTRACTDespite that clinical trials have been examining the safety profile of coronavirus disease 2019 (COVID-19) vaccines, there are concerns about long-term side effects as the number of vaccinations increases. Herein, we report a case of new-onset renal-limited anti-myeloperoxidase (MPO) antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis after booster vaccination with the mRNA 1273 (Moderna) vaccine. A 72-year-old woman with no specific past history, and who had a normal renal function, developed ANCA-associated vasculitis following ...
Source: Journal of Korean Medical Science - July 5, 2022 Category: Biomedical Science Authors: Beop Chang Kim Han Seong Kim Kum Hyun Han Sang Youb Han Hyung Ah Jo Source Type: research

A Case Report of MPO-ANCA-Associated Vasculitis Following Heterologous mRNA1273 COVID-19 Booster Vaccination
J Korean Med Sci. 2022 Jul 4;37(26):e204. doi: 10.3346/jkms.2022.37.e204.ABSTRACTDespite that clinical trials have been examining the safety profile of coronavirus disease 2019 (COVID-19) vaccines, there are concerns about long-term side effects as the number of vaccinations increases. Herein, we report a case of new-onset renal-limited anti-myeloperoxidase (MPO) antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis after booster vaccination with the mRNA 1273 (Moderna) vaccine. A 72-year-old woman with no specific past history, and who had a normal renal function, developed ANCA-associated vasculitis following ...
Source: J Korean Med Sci - July 5, 2022 Category: General Medicine Authors: Beop Chang Kim Han Seong Kim Kum Hyun Han Sang Youb Han Hyung Ah Jo Source Type: research

A Case Report of MPO-ANCA-Associated Vasculitis Following Heterologous mRNA1273 COVID-19 Booster Vaccination
J Korean Med Sci. 2022 Jul 4;37(26):e204. doi: 10.3346/jkms.2022.37.e204.ABSTRACTDespite that clinical trials have been examining the safety profile of coronavirus disease 2019 (COVID-19) vaccines, there are concerns about long-term side effects as the number of vaccinations increases. Herein, we report a case of new-onset renal-limited anti-myeloperoxidase (MPO) antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis after booster vaccination with the mRNA 1273 (Moderna) vaccine. A 72-year-old woman with no specific past history, and who had a normal renal function, developed ANCA-associated vasculitis following ...
Source: Journal of Korean Medical Science - July 5, 2022 Category: Biomedical Science Authors: Beop Chang Kim Han Seong Kim Kum Hyun Han Sang Youb Han Hyung Ah Jo Source Type: research

A Case Report of MPO-ANCA-Associated Vasculitis Following Heterologous mRNA1273 COVID-19 Booster Vaccination
J Korean Med Sci. 2022 Jul 4;37(26):e204. doi: 10.3346/jkms.2022.37.e204.ABSTRACTDespite that clinical trials have been examining the safety profile of coronavirus disease 2019 (COVID-19) vaccines, there are concerns about long-term side effects as the number of vaccinations increases. Herein, we report a case of new-onset renal-limited anti-myeloperoxidase (MPO) antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis after booster vaccination with the mRNA 1273 (Moderna) vaccine. A 72-year-old woman with no specific past history, and who had a normal renal function, developed ANCA-associated vasculitis following ...
Source: J Korean Med Sci - July 5, 2022 Category: General Medicine Authors: Beop Chang Kim Han Seong Kim Kum Hyun Han Sang Youb Han Hyung Ah Jo Source Type: research

A Case Report of MPO-ANCA-Associated Vasculitis Following Heterologous mRNA1273 COVID-19 Booster Vaccination
J Korean Med Sci. 2022 Jul 4;37(26):e204. doi: 10.3346/jkms.2022.37.e204.ABSTRACTDespite that clinical trials have been examining the safety profile of coronavirus disease 2019 (COVID-19) vaccines, there are concerns about long-term side effects as the number of vaccinations increases. Herein, we report a case of new-onset renal-limited anti-myeloperoxidase (MPO) antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis after booster vaccination with the mRNA 1273 (Moderna) vaccine. A 72-year-old woman with no specific past history, and who had a normal renal function, developed ANCA-associated vasculitis following ...
Source: Journal of Korean Medical Science - July 5, 2022 Category: Biomedical Science Authors: Beop Chang Kim Han Seong Kim Kum Hyun Han Sang Youb Han Hyung Ah Jo Source Type: research

A Case Report of MPO-ANCA-Associated Vasculitis Following Heterologous mRNA1273 COVID-19 Booster Vaccination
J Korean Med Sci. 2022 Jul 4;37(26):e204. doi: 10.3346/jkms.2022.37.e204.ABSTRACTDespite that clinical trials have been examining the safety profile of coronavirus disease 2019 (COVID-19) vaccines, there are concerns about long-term side effects as the number of vaccinations increases. Herein, we report a case of new-onset renal-limited anti-myeloperoxidase (MPO) antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis after booster vaccination with the mRNA 1273 (Moderna) vaccine. A 72-year-old woman with no specific past history, and who had a normal renal function, developed ANCA-associated vasculitis following ...
Source: J Korean Med Sci - July 5, 2022 Category: General Medicine Authors: Beop Chang Kim Han Seong Kim Kum Hyun Han Sang Youb Han Hyung Ah Jo Source Type: research

A Case Report of MPO-ANCA-Associated Vasculitis Following Heterologous mRNA1273 COVID-19 Booster Vaccination
J Korean Med Sci. 2022 Jul 4;37(26):e204. doi: 10.3346/jkms.2022.37.e204.ABSTRACTDespite that clinical trials have been examining the safety profile of coronavirus disease 2019 (COVID-19) vaccines, there are concerns about long-term side effects as the number of vaccinations increases. Herein, we report a case of new-onset renal-limited anti-myeloperoxidase (MPO) antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis after booster vaccination with the mRNA 1273 (Moderna) vaccine. A 72-year-old woman with no specific past history, and who had a normal renal function, developed ANCA-associated vasculitis following ...
Source: Journal of Korean Medical Science - July 5, 2022 Category: Biomedical Science Authors: Beop Chang Kim Han Seong Kim Kum Hyun Han Sang Youb Han Hyung Ah Jo Source Type: research

Methylprednisolone and Hyaluronic Acid versus Each Agent Alone to Control Complication of Impacted Wisdom Removal
CONCLUSION: Combined use of methylprednisolone sodium succinate and hyaluronic acid significantly decrease postoperative complications than using each agent alone.PMID:35368756 | PMC:PMC8970876 | DOI:10.1155/2022/1563513 (Source: Evidence-based Complementary and Alternative Medicine)
Source: Evidence-based Complementary and Alternative Medicine - April 4, 2022 Category: Complementary Medicine Authors: Alaa Abdelqader Altaweel Abd El-Hamid Gaber Mahmoud Zuhair Alnaffar Elham Ahmed Alshomrani Rahaf Asaad Alrehaili Rahaf Abdulmoeen Alshaikh Jumana Nader Baeshin Elaf Sami Al-Akhdar Source Type: research